pharma-company /Medicinal products /Active ingredients

Rx · PZN 16740845, 18776623

ALYMSYS 25 mg/ml 400mg concentrate for preparation of a solution for infusion vial

German trade nameALYMSYS 25 mg-ml 400mg Konzentrat zur Herstellung einer Infusionslösung Durchstechflasche

Active ingredientBevacizumabPharmaceutical formConcentrate for solution for infusion

Available with fluctuations

4.2

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Average purchase price (B2B)

~ €974

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for ALYMSYS 25 mg/ml 400mg concentrate for preparation of a solution for infusion vial.

Review purchasing terms

ALYMSYS 25 mg/ml 400mg concentrate for preparation of a solution for infusion vial contains the active ingredient Bevacizumab and comes as Concentrate for solution for infusion. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 4.2 out of 10. The best-available pack was available with fluctuations.


Pack sizes · 2 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
167408453.84.2~ €974
187766230.00.0~ €974

Availability of ALYMSYS 25 mg/ml 400mg concentrate for preparation of a solution for infusion vial fluctuates noticeably. We are happy to advise you on securing your supply through additional sources.

Secure your supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 2 recorded PZNs.